Browsing by Author "Armisen, Ricardo"

Now showing items 1-3 of 3

    • Differential miRNA expression profiling reveals miR-205-3p to be a potential radiosensitizer for low- dose ... 
      Andaur, Rodrigo; Tapia, Julio C.; Moreno, José; Soto, Leopoldo; Armisen, Ricardo; Marcelain Cubillos, Katherine (Impact Journals LLC, 2018)
      © Andaur et al. Enhanced radiosensitivity at low doses of ionizing radiation (IR) (0.2 to 0.6 Gy) has been reported in several cell lines. This phenomenon, known as low doses hyperradiosensitivity (LDHRS), appears as an ...
    • Major Histocompatibility Complex Class I-Related Chain A (MICA) allelic variants associate with susceptibility ... 
      Toledo Stuardo, Karen; Ribeiro, Carolina H.; Canals Cifuentes, María Andrea; Morales, Marcela; Gárate, Valentina; Rodríguez Siza, José; Tello, Samantha; Bustamante, Marco; Armisen, Ricardo; Matthies Eyzaguirre, Douglas Johans; Zapata Torres, Gerald Amilcar; González Hormazábal, Patricio; Molina Sampayo, María Carmen (Frontiers Media, 2021)
      Gastric cancer (GC) is the fifth most prevalent type of cancer worldwide. Gastric tumor cells express MICA protein, a ligand to NKG2D receptor that triggers natural killer (NK) cells effector functions for early tumor ...
    • Validation of an NGS panel designed for detection of actionable mutations in tumors common in latin america 
      Salvo, Mauricio; González Feliu, Evelin; Toro, Jéssica; Gallegos Méndez, Iván; Maureira Caviedes, Ignacio Andrés; Miranda González, Nicolás; Barajas Barajas, Olga Beatriz; Bustamante, Eva; Ahumada Olea, Mónica Beatriz; Colombo Flores, Alicia Angelina; Armisen, Ricardo; Villaman, Camilo; Ibáñez, Carolina; Bravo, María Loreto; Sanhueza, Verónica; Spencer, M. Loreto; Toro, Gonzalo de; Morales, Erik; Bizama, Carolina; García, Patricia; Carrasco, Ana María; Gutiérrez Cordero, Lorena; Bermejo, Justo; Verdugo Salgado, Ricardo Alejandro; Marcelain Cubillos, Katherine Jenny (MDPI, 2021)
      Next-generation sequencing (NGS) is progressively being used in clinical practice. However, several barriers preclude using this technology for precision oncology in most Latin American countries. To overcome some of these ...